CycloSPORINE (EENT)

Brand names: Restasis
Drug class: Antineoplastic Agents , Antineoplastic Agents

Usage of CycloSPORINE (EENT)

Keratoconjunctivitis Sicca

Used to increase tear production in adults whose tear production presumably is suppressed secondary to ocular inflammation related to keratoconjunctivitis sicca.

Increased tear production not observed in patients already receiving topical anti-inflammatory agents or using punctal plugs.

Relate drugs

How to use CycloSPORINE (EENT)

Administration

For ophthalmic use only. Not for injection. Not for subconjunctival injection or introduction directly into the anterior chamber of the eye.

Ophthalmic Administration

Apply topically to the eye as an ophthalmic emulsion.

Avoid contamination of emulsion container.

Invert unit-dose vial a few times before use to obtain a uniform, opaque, white emulsion.

Preservative-free emulsion is for single use only in one or both eyes; discard any unused portion immediately after administration.

Remove contact lenses prior to administration; may reinsert lenses 15 minutes after dose.

When used concomitantly with artificial tears, administer ophthalmic preparations at least 15 minutes apart.

Dosage

Adults

Keratoconjunctivitis Sicca Ophthalmic

1 drop of a 0.05% emulsion into each eye twice daily, approximately 12 hours apart.

Warnings

Contraindications

  • Known hypersensitivity to cyclosporine or any ingredient in the formulation.
  • Active ocular infections.

    • Warnings/Precautions

    Warnings

    Safety and efficacy not established in patients with history of herpes keratitis.

    Specific Populations

    Pregnancy

    Category C.

    Lactation

    Distributed into milk after systemic administration; it is not known whether distributed into milk after topical application to the eye. Caution advised if used in nursing women.

    Pediatric Use

    Safety and efficacy not established in children <16 years of age.

    Geriatric Use

    No substantial differences in safety and efficacy relative to younger adults.

    Common Adverse Effects

    Ocular burning, conjunctival hyperemia, discharge, epiphora, ocular pain, foreign body sensation, pruritus, stinging, visual disturbance (e.g., blurring).

    What other drugs will affect CycloSPORINE (EENT)

    No formal drug interaction studies to date.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords

    AI Assitant